Literature DB >> 23160880

Impact of ACE2 deficiency and oxidative stress on cerebrovascular function with aging.

Ricardo A Peña Silva1, Yi Chu, Jordan D Miller, Ian J Mitchell, Josef M Penninger, Frank M Faraci, Donald D Heistad.   

Abstract

BACKGROUND AND
PURPOSE: Angiotensin II produces oxidative stress and endothelial dysfunction in cerebral arteries, and angiotensin II type I receptors may play a role in longevity and vascular aging. Angiotensin-converting enzyme type 2 (ACE2) converts angiotensin II to angiotensin (1-7) and thus, may protect against effects of angiotensin II. We hypothesized that ACE2 deficiency increases oxidative stress and endothelial dysfunction in cerebral arteries and examined the role of ACE2 in age-related cerebrovascular dysfunction.
METHODS: Endothelial function, expression of angiotensin system components, NADPH oxidase subunits, and proinflammatory cytokines were examined in cerebral arteries from adult (12 months old) and old (24 months old) ACE2 knockout (KO) and wild-type (WT) mice. The superoxide scavenger tempol was used to examine the role of oxidative stress on endothelial function.
RESULTS: Vasodilatation to acetylcholine was impaired in adult ACE2 KO (24±6% [mean±SE]) compared with WT mice (52±7%; P<0.05). In old mice, vasodilatation to acetylcholine was impaired in WT mice (29±6%) and severely impaired in ACE2 KO mice (7±5%). Tempol improved endothelial function in adult and old ACE2 KO and WT mice. Aging increased mRNA for tumor necrosis factor-α in WT mice, and significantly increased mRNA levels of NAPDH oxidase 2, p47(phox), and Regulator of calcineurin 1 in both ACE2 KO and WT mice. mRNA levels of angiotensin system components did not change during aging.
CONCLUSIONS: ACE2 deficiency impaired endothelial function in cerebral arteries from adult mice and augmented endothelial dysfunction during aging. Oxidative stress plays a critical role in cerebrovascular dysfunction induced by ACE2 deficiency and aging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23160880      PMCID: PMC3529166          DOI: 10.1161/STROKEAHA.112.667063

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  46 in total

1.  ACE2 gene polymorphism and essential hypertension: an updated meta-analysis involving 11,051 subjects.

Authors:  Na Lu; Yang Yang; Yibo Wang; Yan Liu; Gang Fu; Dongmei Chen; Hui Dai; Xiaohan Fan; Rutai Hui; Yang Zheng
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

2.  Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase.

Authors:  Chad Vickers; Paul Hales; Virendar Kaushik; Larry Dick; James Gavin; Jin Tang; Kevin Godbout; Thomas Parsons; Elizabeth Baronas; Frank Hsieh; Susan Acton; Michael Patane; Andrew Nichols; Peter Tummino
Journal:  J Biol Chem       Date:  2002-01-28       Impact factor: 5.157

3.  Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery.

Authors:  K Feterik; L Smith; Z S Katusic
Journal:  Brain Res       Date:  2000-08-04       Impact factor: 3.252

Review 4.  ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors.

Authors:  Anthony J Turner; Sarah R Tipnis; Jodie L Guy; Gillian Rice; Nigel M Hooper
Journal:  Can J Physiol Pharmacol       Date:  2002-04       Impact factor: 2.273

5.  Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events.

Authors:  Paul V Targonski; Piero O Bonetti; Geralyn M Pumper; Stuart T Higano; David R Holmes; Amir Lerman
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

6.  Angiotensin-converting enzyme 2 is an essential regulator of heart function.

Authors:  Michael A Crackower; Renu Sarao; Gavin Y Oudit; Chana Yagil; Ivona Kozieradzki; Sam E Scanga; Antonio J Oliveira-dos-Santos; Joan da Costa; Liyong Zhang; York Pei; James Scholey; Carlos M Ferrario; Armen S Manoukian; Mark C Chappell; Peter H Backx; Yoram Yagil; Josef M Penninger
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

7.  Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke.

Authors:  Mario Di Napoli; Francesca Papa
Journal:  Stroke       Date:  2003-11-06       Impact factor: 7.914

8.  Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas.

Authors:  Robson A S Santos; Ana C Simoes e Silva; Christine Maric; Denise M R Silva; Raquel Pillar Machado; Insa de Buhr; Silvia Heringer-Walther; Sergio Veloso B Pinheiro; Myriam Teresa Lopes; Michael Bader; Elizabeth P Mendes; Virgina Soares Lemos; Maria Jose Campagnole-Santos; Heinz-Peter Schultheiss; Robert Speth; Thomas Walther
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

9.  Severe acute respiratory syndrome, Beijing, 2003.

Authors:  Wannian Liang; Zonghan Zhu; Jiyong Guo; Zejun Liu; Weigong Zhou; Daniel P Chin; Anne Schuchat
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

10.  No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension.

Authors:  Adam V Benjafield; William Y S Wang; Brian J Morris
Journal:  Am J Hypertens       Date:  2004-07       Impact factor: 2.689

View more
  50 in total

Review 1.  Regulation of exercise blood flow: Role of free radicals.

Authors:  Joel D Trinity; Ryan M Broxterman; Russell S Richardson
Journal:  Free Radic Biol Med       Date:  2016-02-10       Impact factor: 7.376

2.  Different effects of the deletion of angiotensin converting enzyme 2 and chronic activation of the renin-angiotensin system on muscle weakness in middle-aged mice.

Authors:  Hikari Takeshita; Koichi Yamamoto; Masaki Mogi; Satoko Nozato; Masatsugu Horiuchi; Hiromi Rakugi
Journal:  Hypertens Res       Date:  2019-12-19       Impact factor: 3.872

Review 3.  Microvascular NADPH oxidase in health and disease.

Authors:  Yao Li; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2017-03-06       Impact factor: 7.376

4.  Stages in Discovery: Angiotensin-Converting Enzyme Type 2 and Stroke.

Authors:  Ricardo A Peña-Silva; Donald D Heistad
Journal:  Hypertension       Date:  2015-05-04       Impact factor: 10.190

5.  Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.

Authors:  Yang Zhang; Jian Liu; Jiang-Yun Luo; Xiao Yu Tian; Wai San Cheang; Jian Xu; Chi Wai Lau; Li Wang; Wing Tak Wong; Chi Ming Wong; Hui Yao Lan; Xiaoqiang Yao; Mohan K Raizada; Yu Huang
Journal:  Antioxid Redox Signal       Date:  2015-05-14       Impact factor: 8.401

6.  Promising neuroprotective effects of the angiotensin-(1-7)-angiotensin-converting enzyme 2-Mas axis in stroke.

Authors:  Ricardo A Peña Silva; Donald D Heistad
Journal:  Exp Physiol       Date:  2014-02       Impact factor: 2.969

7.  Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence.

Authors:  Jiao-Lin Zheng; Guang-Ze Li; Shu-Zhen Chen; Jin-Ju Wang; James E Olson; Hui-Jing Xia; Eric Lazartigues; Yu-Lan Zhu; Yan-Fang Chen
Journal:  CNS Neurosci Ther       Date:  2014-03-02       Impact factor: 5.243

8.  Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction.

Authors:  J Zheng; G Li; S Chen; J Bihl; J Buck; Y Zhu; H Xia; E Lazartigues; Y Chen; J E Olson
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

9.  Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation.

Authors:  Sophocles Chrissobolis; Grant R Drummond; Frank M Faraci; Christopher G Sobey
Journal:  J Hypertens       Date:  2014-09       Impact factor: 4.844

10.  Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer's disease.

Authors:  Anna Csiszar; Stefano Tarantini; Gábor A Fülöp; Tamas Kiss; M Noa Valcarcel-Ares; Veronica Galvan; Zoltan Ungvari; Andriy Yabluchanskiy
Journal:  Geroscience       Date:  2017-08-29       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.